| Primary information |
|---|
| sequence ID | Seq_3552 |
| Peptide sequence | HTFMGVVSLGSPSGEVSHPR |
| CancerPDF_ID | CancerPDF_ID1672, CancerPDF_ID1673, CancerPDF_ID3210, |
| PMID | 21136997,21136997,21136997 |
| Protein Name | Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein |
| UniprotKB Entry Name | FETUA_HUMAN,FETUA_HUMAN,FETUA_HUMAN |
| Fluid | Serum,Serum,Plasma |
| M/Z | 2080.01601,2096.01092,2080.016 |
| Charge | 1,1,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS |
| Quantification Technique | LC-ESI-MS,LC-ESI-MS,LC-ESI-MS |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,NA |
| CancerPDF_ID | CancerPDF_ID1672, CancerPDF_ID1673, CancerPDF_ID3210, |
| p-Value | NA,NA,NA |
| Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
| Length | 20,20,20 |
| Cancer Type | Colorectal cancer,Colorectal cancer,Normal |
| Database | SwissProt Database,SwissProt Database,SwissProt Database |
| Modification | NA,Oxidation of Met,NA |
| Number of Patients | 30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals |
| Regulation | NA,NA,NA |
| Validation | Leave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |